SEARCH

SEARCH BY CITATION

  • 1
    Trinchieri, G., Biology of natural killer cells. Adv. Immunol. 1990. 47: 187376.
  • 2
    Cooper, M.-A., Fehniger, T.-A. and Caligiuri, M.-A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633640.
  • 3
    Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M.-C. and Moretta, L., Receptors for HLA-class I molecules in human natural killer cells. Annu. Rev. Immunol. 1996. 14: 619648.
  • 4
    Long, E. O., Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 1999. 17: 875904.
  • 5
    Lanier, L.-L., NK receptors. Annu. Rev. Immunol. 1998. 16: 359393.
  • 6
    Lopez-Botet, M., Llano, M. and Ortega, M., Human cytomegalovirus and natural killer-mediated survellance of HLA class I expression: a paradigm of host-pathogen adaptation. Immunol. Rev. 2001. 181: 193202.
  • 7
    Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J.-J., L`opez-Botet, M., Duggan-Keen, M. and Stern, P.-L., Implications for immunosurveillance of altered HLA-class I phenotypes in human tumors. Immunol. Today 1997. 18: 8995.
  • 8
    Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M.-C., Biassoni, R. and Moretta, L., Activating receptors and co-receptors involvedin human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 2001. 19: 197223.
  • 9
    Cerwenka, A. and Lanier, L.-L., Ligands for natural killer cell receptors: redundancy or specifity. Immunol. Rev. 2001. 181: 158169.
  • 10
    Pende, D., Rivera, P., Marcenaro, S., Chang, C.-C., Biassoni, R., Conte, R., Kubin, M., Cosman, D., Ferrone, S., Moretta, L. and Moretta, A., Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of differenthistotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res. 2002. 62: 61786186.
  • 11
    Ferlazzo, G., Tsang, M.-L., Moretta, L., Melioli, G., Steinman, R.-M. and Münz, C., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 2002. 195: 343351.
  • 12
    Gerosa, F., Baldani-Guerra, B., Nisii, C., Mayesini, V., Carra, G. and Trinchieri, G., Reciprocal activating interaction between NK cells and dendritic cells. J. Exp. Med. 2002. 195: 327333.
  • 13
    Piccioli, D., Sbrana, S., Melandri, E. and Valiante, N.-M., Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 2002. 195: 335341.
  • 14
    Moretta, A., Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol. 2002. 2: 957965.
  • 15
    Zitvogel, L., Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 2002. 195: 914.
  • 16
    Ferlazzo, G., Morandi, B., D'Agostino, A., Meazza, R., Melioli, G., Moretta, A. and Moretta, L., The interaction between natural killer and dendritic cell in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol. 2003. 33: 306313.
  • 17
    Ferlazzo, G., Semino, C. and Melioli, G., HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol. Lett. 2001. 76: 3741.
  • 18
    Wilson, J.-L., Heffler, L.-C., Charo, J., Scheynius, A., Bejarano, M.-T. and Ljunggren, H.-G., Targeting of human dendritic cells by autologous NK cells. J. Immunol. 1999. 163: 63656370.
  • 19
    Carbone, E., Terrazzano, G., Ruggiero, G., Zanzi, D., Ottainao, A., Manzo, C., Karre, K. and Zappacosta, S., Recognition of autologous dendritic cells byhuman NK cells. Eur. J. Immunol. 1999. 29: 40224029.
  • 20
    Spaggiari, G.-M., Carosio, R., Pende, D., Marcenaro, S., Rivera, P., Zocchi, M.-R., Moretta, L. and Poggi, A., NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur. J. Immunol. 2001. 31: 16561665.
  • 21
    Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L. and Moretta, A., TGFβ1 inhibits the surface expression of the NKp30 and NKG2D triggering NK receptors: consequences on the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 2003. 100: 41204125.
  • 22
    Velardi, A., Ruggeri, L., Moretta, A. and Moretta, L., NK cells: a lesson from mismatched hematopoietic transplantation. Response from Velardi et al. Trends Immunol. 2003. 24: 910.
  • 23
    Vitale, M., Sivori, S., Pende, D., Moretta, L. and Moretta, A., Coexpression of two functionally indipendent p58 inhibitory receptors in human NK cell clones results in the inability to kill normal allogeneic target cells. Proc. Natl. Acad. Sci. USA 1995. 95: 35363540.
  • 24
    Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque,S., Liu, Y.-J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767811.
  • 25
    Banchereau, J. and Steinman, R.-M., Dendritic cells and the control of immunity. Nature 1998. 392: 245252.
  • 26
    Sallusto, F. and Lanzavecchia, A., Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J. Exp. Med. 1999. 189: 611614.
  • 27
    De Baey, A. and Lanzavecchia, A., The role of aquaporins in dendritic cell macropinocytosis. J. Exp. Med. 2000. 191: 743747.
  • 28
    Lee, N., Goodlett, D.-R., Ishitani, A., Marquardt, H. and Geraghty, D.-E., HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 1998. 160: 49514960.
  • 29
    Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I. and Lanzavecchia, A., Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 1999. 189: 821829.
  • 30
    Allavena, P., Sica, A., Vecchi, A., Locati, M., Sozzani, S. and Mantovani, A., The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol. Rev. 2000. 177: 141149.
  • 31
    Dieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S. and Caux, C., Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 1998. 188: 373386.
  • 32
    Saeki, H., Moore, A.-M., Brown, M.-J. and Hwang, S.-T., Secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes. J. Immunol. 1999. 162: 24722475.
  • 33
    Sallusto, F., Mackay, C.-R. and Lanzavecchia, A., The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 2000. 18: 593620.
  • 34
    Kim, C.-H., Pelus, L.-M., Appelbaum, E., Johanson, K. and Broxmeyer, H.-E., CCR7 ligands, SLC/6Ckin/Exodus2/TCA4 and Ckβ-11/MIP-3β/ELC, are chemoattractants for CD56(+) CD16(-) NK cells and late stage lymphoid progenitors. Cell Immunol. 1999. 193: 226235.
  • 35
    Campbell, J.-J., Qin, S., Unutmaz, D., Soler, D., Murphy, K.-E., Hodge, M.-R., Wu, L. and Butcher, E.-C., Unique subpopulations of CD56+ NK and NKT peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J. Immunol. 2001. 166: 64776482.
  • 36
    Ciccone, E., Colonna, M., Viale, O., Pende, D., Di Donato, C., Reinherz, D., Amoroso, A., Jeannet, M., Guardiola, J., Moretta, A., Spies, T., Strominger, J. and Moretta, L., Susceptibility or resistance to lysisby alloreactive NK cells is governed by a gene in the human major histocompatibility complex between Bf and HLA-B. Proc. Natl. Acad. Sci. USA 1990. 87: 97949797.
  • 37
    Pende, D., Accame, L., Pareti, L., Mazzocchi, A., Moretta, A., Parmiani, G. and Moretta, L., The scusceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of HLA class I alleles. Eur. J. Immunol. 1998. 28: 23842394.
  • 38
    Marsh, S.-G.-E., Krausa, P. and Bodmer, J.-G., A preliminary analysis of the 11th international histocompatibility workshop: monoclonal antibodies. Tissue Antigens 1990. 36: 180186.